Rempex Pharmaceuticals Lands $67,500,000 Series B Funding Round

  • Feed Type
  • Date
    11/9/2011
  • Company Name
    Rempex Pharmaceuticals
  • Mailing Address
    11535 Sorrento Valley Rd. San Diego, CA 92121
  • Company Description
    Rempex Pharmaceuticals, Inc. is a biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance.
  • Website
    http://www.rempexpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $67,500,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This financing gives us the resources to rapidly advance our development programs towards commercialization at a time when the need for new treatments for resistant gram-negative infections has become critical.
  • M&A Terms
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    Vivo Ventures
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    OrbiMed
  • Venture Investor
    Adams Street Partners

By posting a comment, you agree to our terms and conditions.